| Literature DB >> 22731714 |
Michael Schumann1, Sarah Kamel, Marie-Luise Pahlitzsch, Lydia Lebenheim, Claudia May, Michael Krauss, Michael Hummel, Severin Daum, Michael Fromm, Jörg-Dieter Schulzke.
Abstract
In celiac disease, the gut-associated immune system is activated in response to the ingestion of gluten, causing an atrophy of the small intestinal mucosa. Although this condition is, in most cases, responsive to a gluten-free diet, celiac disease refractory to treatment occurs in a small percentage of celiacs. An epithelial barrier defect is known to be an integral part of celiac pathophysiology. However, the mucosa in refractory celiac disease underlies a constant inflammatory process. The epithelial barrier has not been addressed in this condition so far. Herein, the tight junction-associated barrier in refractory celiac disease is investigated functionally and structurally. Although normally expressed in celiac disease, claudin-4 is shown to be downregulated in refractory cases, presumably by two mechanisms, reduced protein expression and increased claudin endocytosis. Furthermore, the tightening claudin-5 is downregulated and the pore-forming claudin-2 is upregulated.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22731714 DOI: 10.1111/j.1749-6632.2012.06565.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691